Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMAD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
APOC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PP12613 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HBB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00961 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFRKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMRTC1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00184 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPS8L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPPR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD45C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRASLS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on